Eagle Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
EGRX Eagle Pharmaceuticals Inc
CFVIU CF Acquisition Corp VI
JPM-C JPMorgan Chase & Co
OSK Oshkosh Corp
VSTO Vista Outdoor Inc
THMO Thermogenesis Holdings Inc
CNK Cinemark Holdings Inc
EEENF 88 Energy Ltd
KO Coca-Cola Co
C Citigroup Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Eagle Pharmaceuticals, Inc. is an integrated pharmaceutical company. The Company takes a molecule from preclinical research through regulatory approval and into the marketplace, including development, manufacturing and commercialization. The Company identifies challenging-to-treat diseases of the central nervous system or metabolic critical care therapeutic areas, as well as in oncology. The Company offers three products: Ryanodex, dantrolene sodium) (Ryanodex), bendamustine ready-to-dilute (RTD) 500ml solution (Belrapzo), and rapidly infused bendamustine RTD (Bendeka). The Company market Ryanodex and Belrapzo, and Teva Pharmaceutical Industries Ltd. (Teva) markets Bendeka a lyophilized powder formulation of bendamustine hydrochloride in Japan.

Price
Delayed
$45.48
Day's Change
-1.74 (-3.68%)
Bid
--
Ask
--
B/A Size
--
Day's High
47.72
Day's Low
44.70
Volume
(Heavy Day)

Today's volume of 88,196 shares is on pace to be much greater than EGRX's 10-day average volume of 97,022 shares.

88,196
  • Prev Close
    47.21
  • Today's Open
    47.08
  • Day's Range
    44.70-47.72
  • Avg Vol (10-day)
    97.0K
  • Last (time)
    1:28p ET 01/18/22
  • Last (size)
    6
  • 52-Wk Range
    36.48 - 58.25
    LowHigh
  • (06/02/21 - 10/04/21)
    24.66%
  • 40.0%
  • Market Cap
    587.6M
  • Shares Outstanding
    12.9M
  • 0.41
  • 113.88x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 92.20
  • (% of float 12/31/21)
    5.14

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.